The Diagnostic Imaging MRI modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of MRI across the healthcare continuum, including breast, neurological, cardiovascular, prostate imaging, and more.
April 16th 2025
An emerging nomogram model for intra-tumoral heterogeneity quantification with breast MRI demonstrated an average 85 percent sensitivity in external validation testing for predicting pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
43rd Annual CFS: Innovative Cancer Therapy for Tomorrow®
November 12-14, 2025
Register Now!
20th Annual New York Lung Cancers Symposium®
November 15, 2025
Register Now!
Annual Hawaii Cancer Conference
January 24-25, 2026
Register Now!
43rd Annual Miami Breast Cancer Conference®
March 5-8, 2026
Register Now!
19th Annual New York GU Cancers Congress™
March 13-14, 2026
Register Now!
Mastering Advances in Managing Unresectable and Metastatic NSCLC—Immunotherapy, Targeted Therapies, and Emerging Strategies
View More
(CME Credit) Advancing Outcomes in Limited-Stage Small Cell Lung Cancer: From Evidence to Practice
View More
Key European committee advises against Magnevist use in patients with weak kidneys
July 12th 2007The European Pharmacovigilance Working Party has recommended that Magnevist (from Bayer Schering) be contraindicated in patients with severe or end-stage renal impairment to help prevent a life-threatening skin disease linked to gadolinium-enhanced MRI, according to industry and U.K. regulatory sources.
Myriad holds monopoly for BRCA1/BRCA2 testing
July 1st 2007Myriad Genetics is the only place to go for BRCA1/BRCA2 mutation testing. The Salt Lake City biopharmaceutical company has a monopoly on the test. Its scientists discovered the BRCA1 and BRCA2 genes in 1996 and patented their use for assessing the risk of genetically related cancer.
Virtual gadolinium safety tango enlivens Roentgen Ray meeting
July 1st 2007Like other medical journalists, I can usually be found in the front rows of the radiology meeting lecture halls, dutifully taking copious notes. The American Roentgen Ray Society meeting in May was no exception. But this time I was also under a vow of silence for three weeks, after a vocal cord nodule diagnosis.
Breast MRI wins allies, while CAD survives attack
July 1st 2007In a flash, after the American Cancer Society guidelines came out in favor of breast MRI for high-risk screening in late March, prominent radiology preauthorization company CareCore proclaimed it had been ahead of the times. The ACS release was a major coup for the technique.
Study favors MRI over CT for acute stroke diagnosis
July 1st 2007An influential trial has left neuroradiologists in a quandary about the best imaging approach for the initial evaluation of acute stroke. The single-center prospective trial concluded that MRI accurately diagnoses acute stroke while noncontrast CT, the old gold standard, is about as accurate as a coin flip.
DNA tests find unexpected link to Spanish Inquisition
July 1st 2007Monty Python, the British comedy troupe, got it at least partially wrong. Contrary to the claim of their legendary skit involving Catholic cardinals, a matronly lady, and torture in a comfy chair, one can expect the Spanish Inquisition. An Albequerque oncologist has found evidence of Spain's infamous campaign to rid itself and its territories of heretics by testing Hispanic women in northern New Mexico for BRCA1/BRCA2 mutations.
Genetic testing taps at-risk women for MRI monitoring
July 1st 2007Some women who carry a strong genetic susceptibility to cancer have consented to the surgical removal of their breasts to avoid likely cancer. The combination of reliable genetic testing, however, and close surveillance using breast MRI, mammography, and ultrasound now offers an alternative to such excision or the acceptance of a strong possibility of cancer.
Autistic children face fMRI's gaze
July 1st 2007Dr. Susan Bookheimer and colleagues at the University of California, Los Angeles have confirmed through functional MRI that levels of brain function are low or nonexistent in autistic patients viewing stimuli designed to provoke emotional activity, according to studies presented at the 2007 International Meeting for Autism Research.
MR imaging challenges CT in gastrointestinal tract
July 1st 2007Many problems associated with the gastrointestinal tract occur in young patients. The use of repeated CT scans to evaluate these patients over the course of years is questionable, however, given the repeated exposure to ionizing radiation. MRI is proving to be a reliable tool to image the small bowel as well as the colon, according to Dr. Thomas C. Lauenstein, an assistant professor of radiology at Emory University.
Is that your nose growing, doctor?
July 1st 2007How much would you pay to avoid spending the rest of your life in prison: $2 million? How about 30 years in prison: $1 million? Even if we lowball it and say a radiologist makes about $250,000 a year, 30 years of your life would be worth more like $7.5 million. What if I told you it would cost you only $10,000. A steal, right?
Sonography reveals causes of acute or chronic groin pain
July 1st 2007Groin pain, whether acute or chronic, is a common clinical presentation that can be caused by a diverse array of disorders involving different anatomic structures. This makes definitive diagnosis difficult for even the most experienced clinician. Imaging can be invaluable in both localizing and characterizing otherwise uncertain groin pathology.
Early results from Alzheimer’s neuroimaging studies could speed research
June 19th 2007Alzheimer’s disease researchers may be able to reduce the time and expense associated with clinical trials, according to early results from the Alzheimer’s Disease Neuroimaging Initiative (ADNI), a public-private research partnership organized by the National Institutes of Health.
Ultrasound proves equal to MRI for assessing heart valve in cardiomyopathy
June 18th 2007Real-time 3D echocardiography can measure mitral annular size and function as accurately as MRI, according to Egyptian researchers. They studied patients with both hypertrophic cardiomyopathy and dilated cardiomyopathy.
Report from SNM: Hybrid PET/MR imaging of brain debuts at annual meeting
June 5th 2007Researchers from Germany and the U.S. released findings from the first study showing images of the human brain acquired simultaneously by the two modalities of a hybrid PET/MR scanner. They released the data at the 2007 Society of Nuclear Medicine meeting being held in Washington, DC.
Initial research challenges contrast reaction dogma
June 1st 2007Contrary to conventional wisdom, patients with life-threatening adverse reactions to contrast media may be truly allergic to certain agents, the same way people are allergic to dust or pollen. The evidence so far is preliminary, but if it is borne out by further research, the finding would have significant implications for the administration of contrast agents.
Baby-boomers can expect better imaging of age-related changes
June 1st 2007If ever a generation has been obsessed with aging, it's the baby-boom generation. Thirty years' worth of fads in exercise, diets, fashion, and personal grooming have all been directed at slowing the aging process or hiding its effects. Well, boomers can run (or jog, or bike, or yoga), but they won't be able to hide from what radiologists may soon be able to tell about the age of their insides.
Agfa plans ahead for coming demise of best-of-breed IT products
June 1st 2007When the best-of-breed information systems that now facilitate the practice of medicine have outlived their usefulness, Agfa Healthcare will be ready with the next generation of IT, if the president of Agfa Healthcare has his way.
European radiologists bask in glow of MR blood pool images
June 1st 2007Peripheral MR angiography is improved on first-pass imaging due to the high relaxivity of the MR blood pool agent Vasovist. The extended imaging window provided by the agent supports steady-state imaging not possible with other MR contrast media, producing ultrahigh spatial resolution MRA (second pass) demonstrating both arteries and veins in detail.
Diffusion maps of bone mets indicate therapy response
June 1st 2007Diffusion-weighted MR of the bone may indicate within days whether and how well patients with metastatic cancer of the bone are responding to treatment. The software to support such conclusions is now being developed for commercial release later this year by Cedara Software.
MRI, CT offer answers to renal mass queries
June 1st 2007The widespread use of cross-sectional imaging techniques means that renal masses are now a common incidental finding. The term renal mass covers a diverse group of pathologic entities, including inflammatory, vascular, and benign tumors and neoplastic lesions.
3T MRI accurately stages rectal cancer, identifies candidates for sphincter-sparing surgery
May 25th 2007Patients examined at the Qilu Hospital of Shandong University in China for rectal cancer benefit from the added diagnostic power of 3T MRI for staging and identifying candidates for sphincter-sparing surgery.